Di Minin G, Holzner M, Grison A, Dumeau C, Chan W, Monfort A, et al. TMED2 binding restricts SMO to the ER and Golgi compartments. PLoS Biol. 2022;20:e3001596 pubmed publisher

Ngo T, Wilkins B, So S, Keov P, Chahal K, Finch A, et al. Orphan receptor GPR37L1 remains unliganded. Nat Chem Biol. 2021;17:383-386 pubmed publisher

Chahal K, Li J, Kufareva I, Parle M, Durden D, Wechsler Reya R, et al. Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma. PLoS ONE. 2019;14:e0214901 pubmed publisher

Lee Y, Patil S, Golz C, Strohmann C, Ziegler S, Kumar K, et al. A ligand-directed divergent catalytic approach to establish structural and functional scaffold diversity. Nat Commun. 2017;8:14043 pubmed publisher

Taipale J, Chen J, Cooper M, Wang B, Mann R, Milenkovic L, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature. 2000;406:1005-9 pubmed